Knu Pharma Engineers And Consultant Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 30-10-2024
- Paid Up Capital ₹ 0.20 M
as on 30-10-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 295.12%
(FY 2023)
- Profit 96.92%
(FY 2023)
- Ebitda 114.70%
(FY 2023)
- Net Worth 85.91%
(FY 2023)
- Total Assets 85.34%
(FY 2023)
About Knu Pharma Engineers And Consultant
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Ramilaben Patel and Kanaiyalal Patel serve as directors at the Company.
- CIN/LLPIN
U29297GJ2020PTC118885
- Company No.
118885
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Knu Pharma Engineers And Consultant?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanaiyalal Patel  | Director | 16-Dec-2020 | Current |
| Ramilaben Patel | Director | 16-Dec-2020 | Current |
Financial Performance of Knu Pharma Engineers And Consultant.
Knu Pharma Engineers And Consultant Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 295.12% increase. The company also saw a substantial improvement in profitability, with a 96.92% increase in profit. The company's net worth Soared by an impressive increase of 85.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Knu Pharma Engineers And Consultant?
Unlock access to Knu Pharma Engineers And Consultant's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Knu Pharma Engineers And Consultant?
Knu Pharma Engineers And Consultant has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Knu Pharma Engineers And Consultant, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Knu Pharma Engineers And Consultant's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
